INFINITY TEAMS WITH JOHNSON & JOHNSON ON DRUG DISCOVERY

Infinity Pharmaceuticals Inc., an anti-cancer drug-discovery company, has announced a collaborative deal with a partner to identify new drugs using the company's collection of compounds. The Cambridge company will work with Johnson & Johnson Pharmaceutical Research & Development, a division of Janssen Pharmaceutica. Financial details weren't disclosed, but Johnson & Johnson will pay an upfront license fee and has also invested in Infinity.

Boston Business Journal (http://www.bizjournals.com/boston/stories/2005/01/03/daily62.html)